Psychopharmacology Reconsidered

Psychopharmacology Reconsidered

A Concise Guide Exploring the Limits of Diagnosis and Treatment

Lichtenberg, Pesach; Belmaker, Robert Haim

Springer International Publishing AG

10/2024

220

Mole

9783031403736

15 a 20 dias

Descrição não disponível.
Biochemical basis for psychopharmacology in the brain synapse.-Are DSM or ICD diagnoses the basis for scientific use of psychopharmacologic drugs.-The clinical control trial: What it is, what is has been and does it have a future?.-Antidepressant drugs: For anyone sad or only for the melancholic depressed?.-Antipsychotic drugs: Do they define schizophrenia or do they depress all emotions?.-Antianxiety medications: Are they addictive or are they mankind's precious heritage?.-Mood stabilizers: Is lithium the gold standard?.-Electroconvulsive therapy, transcranial magnetic stimulation and deep brain stimulation.-Addictive substances and pain medication.-Stimulant drugs: Are they specific for attention deficit disorder and are they abused and overused?.-Drugs for Alzheimer's and other dementia: Are they worth anything?.-Drugs for obsessive compulsive disorder: could such obviously psychological disorders have a pharmacological treatment?.-Cannabis: A Useful Psychotropic?.-The placeboresponse in psychopharmacology and the use of nutraceuticals in clinical psychiatry.-Chapter 15: Is there a potential for new treatments in psychopharmacology or have we picked all the low hanging fruit?
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Psychopharmacology;Psychiatric Disorder;Synaptogenesis;Psychoactive Drug;Neuronal Differentiation